These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

636 related items for PubMed ID: 28673499

  • 1. Occult hepatitis B infection and transfusion-transmission risk.
    Candotti D, Boizeau L, Laperche S.
    Transfus Clin Biol; 2017 Sep; 24(3):189-195. PubMed ID: 28673499
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NAT Study Group.
    Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening.
    Seed CR, Kiely P.
    Vox Sang; 2013 Nov; 105(4):290-8. PubMed ID: 23802710
    [Abstract] [Full Text] [Related]

  • 5. Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?
    Dodd RY, Nguyen ML, Krysztof DE, Notari EP, Stramer SL.
    Transfusion; 2018 Sep; 58(9):2166-2170. PubMed ID: 30144082
    [Abstract] [Full Text] [Related]

  • 6. Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan.
    Taira R, Satake M, Momose S, Hino S, Suzuki Y, Murokawa H, Uchida S, Tadokoro K.
    Transfusion; 2013 Jul; 53(7):1393-404. PubMed ID: 23033944
    [Abstract] [Full Text] [Related]

  • 7. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group.
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [Abstract] [Full Text] [Related]

  • 8. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X, Ye X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP.
    Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
    [Abstract] [Full Text] [Related]

  • 9. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY.
    Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
    [Abstract] [Full Text] [Related]

  • 10. Infectivity of blood components from donors with occult hepatitis B infection - results from an Australian lookback programme.
    Seed CR, Maloney R, Kiely P, Bell B, Keller AJ, Pink J, Blood Service Medical Services Lookback Team.
    Vox Sang; 2015 Feb; 108(2):113-22. PubMed ID: 25234417
    [Abstract] [Full Text] [Related]

  • 11. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP.
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP.
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [Abstract] [Full Text] [Related]

  • 14. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
    Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K.
    Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
    [Abstract] [Full Text] [Related]

  • 15. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [Abstract] [Full Text] [Related]

  • 16. Transfusion-transmitted hepatitis B virus infection.
    Candotti D, Allain JP.
    J Hepatol; 2009 Oct; 51(4):798-809. PubMed ID: 19615780
    [Abstract] [Full Text] [Related]

  • 17. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
    Martin LA, Stramer SL, Kuhns MC, Schlauder GG.
    Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
    [Abstract] [Full Text] [Related]

  • 18. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.
    Kuhns MC, Busch MP.
    Mol Diagn Ther; 2006 Oct; 10(2):77-91. PubMed ID: 16669606
    [Abstract] [Full Text] [Related]

  • 19. A probable case of transfusion-transmitted hepatitis B virus infection in an immunosuppressed recipient caused by an occult HBV-infected donor with negative ID-NAT.
    Leung VK, Lee CK, Chau TN, Cheung WI, Lo FH, Lai KB, Lin CK.
    Transfus Med; 2010 Aug 01; 20(4):276-7. PubMed ID: 20149156
    [No Abstract] [Full Text] [Related]

  • 20. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
    Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA.
    Transfusion; 2005 Aug 01; 45(8):1247-57. PubMed ID: 16078909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.